US FDA approves first clinical trial using embryonic stem cells

Published: 2010-11-29 06:56:00

Updated: 2010-11-29 06:56:00

Cha Bio & Diostech, a local biopharmaceutical company, said on November 24 that the US based Advanced Cell Technology, Inc. (ACT), Cha’s joint research collaborator, received from the US Food and Drug Administration an approval on its Investigational New Drug (IND) application to immediately init...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK